Brazilian national regulatory agency, Government office

Beijing, July 7 Chinese vaccine maker Sinovac has received approval for starting phase-3 clinical trial of its COVID-19 vaccine candidate, CoronaVac, in Brazil.This study will recruit nearly 9,000 healthcare professionals working in CPVID-19 specialised facilities in 12 clinical sites located in several states in Brazil, Sinovac said on Monday.The inclusion of participants is scheduled to start this month after ethical approval is obtained from each clinical site, the company added.The study will be conducted in partnership with Instituto Butantan, a leading Brazilian producer of vaccines."We are pleased to advance to Phase III trials with Butantan, which will allow us one step further to our commitment to developing vaccines for global use and to our mission of supplying vaccines to eliminate human diseases," Weidong Yin, Chairman, President and CEO of Sinovac, said in a statement.The Brazilian National Regulatory Agency, Anvisa, fast-tracked the application for the phase-3 trial due to the public health emergency.Sinovac's Covid-19 vaccine candidate has become only one of three such vaccine candidates to advance to phase-3 trial after AstraZeneca and China National Pharmaceutical Group.The US-based Moderna is also planning to start a phase-3 trial of its Covid-19 vaccine candidate this month.Sinovac Life Sciences Co., Ltd. (Sinovac LS), a wholly owned subsidiary of Sinovac Biotech Ltd., in Brazil initiated the development of an inactivated vaccine against Covid-19 on January 28.The phase-1 and phase-2 trials commenced on April 16 in Jiangsu province of China.A group of healthy adults aged 18-59 years old were vaccinated in the trials.According to the preliminary phase I/II results, there was no serious adverse event after vaccinating a total of 743 volunteers in the trials, demonstrating a good safety profile for the vaccine candidate.Over 90 per cent seroconversion was observed in the phase II clinical trial 14 days after completion of a two-dose vaccination at day 0 and day 14.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

USA-Israel Attack

Assembly Elections 2026

IPL 2026

Stock Market News

Maharashtra News

Mumbai Local

Brazilian National Regulatory Agency, NewsFOLLOW

Brazilian national regulatory agency, Latest News

National :"Action will be taken", says Minister Khachariyawas after unclaimed cash seized by police in Jaipur

Jaipur (Rajasthan) [India], May 21 : Rajasthan Minister Pratap Singh Khachariyawas on late Saturday night said no one will ... ...

Health :Sinovac's COVID-19 vaccine advances to key phase-3 trial

Beijing, July 7 Chinese vaccine maker Sinovac has received approval for starting phase-3 clinical trial of its COVID-19 ... ...